Literature DB >> 25660133

Cognitive and Neurobehavioral Profile in Boys With Duchenne Muscular Dystrophy.

Rudaina Banihani1, Sharon Smile2, Grace Yoon3, Annie Dupuis4, Maureen Mosleh5, Andrea Snider5, Laura McAdam6.   

Abstract

Duchenne muscular dystrophy is a progressive neuromuscular condition that has a high rate of cognitive and learning disabilities as well as neurobehavioral disorders, some of which have been associated with disruption of dystrophin isoforms. Retrospective cohort of 59 boys investigated the cognitive and neurobehavioral profile of boys with Duchenne muscular dystrophy. Full-scale IQ of < 70 was seen in 27%; learning disability in 44%, intellectual disability in 19%; attention-deficit/hyperactivity disorder in 32%; autism spectrum disorders in 15%; and anxiety in 27%. Mutations affecting Dp260 isoform and 5'untranslated region of Dp140 were observed in 60% with learning disability, 50% intellectual disability, 77% with autism spectrum disorders, and 94% with anxiety. No statistically significant correlation was noted between comorbidities and dystrophin isoforms; however, there is a trend of cumulative loss of dystrophin isoforms with declining full-scale IQ. Enhanced psychology testing to include both cognitive and neurobehavioral disorders is recommended for all individuals with Duchenne muscular dystrophy.
© The Author(s) 2015.

Entities:  

Keywords:  Dp140 isoform; Dp71 isoforms; Duchenne muscular dystrophy; behavioral and developmental disorders; cognitive impairment

Mesh:

Substances:

Year:  2015        PMID: 25660133     DOI: 10.1177/0883073815570154

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  43 in total

1.  Neuronal SH-SY5Y cells use the C-dystrophin promoter coupled with exon 78 skipping and display multiple patterns of alternative splicing including two intronic insertion events.

Authors:  Atsushi Nishida; Maki Minegishi; Atsuko Takeuchi; Hiroyuki Awano; Emma Tabe Eko Niba; Masafumi Matsuo
Journal:  Hum Genet       Date:  2015-07-08       Impact factor: 4.132

2.  Autism spectrum disorders are prevalent among patients with dystrophinopathies.

Authors:  Haruo Fujino; Toshio Saito; Tsuyoshi Matsumura; Saki Shibata; Yuko Iwata; Harutoshi Fujimura; Osamu Imura
Journal:  Neurol Sci       Date:  2018-03-28       Impact factor: 3.307

Review 3.  Epilepsy and Autism.

Authors:  Ashura W Buckley; Gregory L Holmes
Journal:  Cold Spring Harb Perspect Med       Date:  2016-04-01       Impact factor: 6.915

4.  Dystrophinopathy-associated dysfunction of Krebs cycle metabolism.

Authors:  Angus Lindsay; Christopher M Chamberlain; Bruce A Witthuhn; Dawn A Lowe; James M Ervasti
Journal:  Hum Mol Genet       Date:  2019-03-15       Impact factor: 6.150

5.  Neurocognitive Impairment in mdx Mice.

Authors:  Clarissa M Comim; Letícia Ventura; Viviane Freiberger; Paula Dias; Daiane Bragagnolo; Matheus L Dutra; Ricardo A Amaral; Ana Lucia S Camargo-Fagundes; Patrícia A Reis; Hugo C Castro-Faria-Neto; Mariz Vainzof; Maria I Rosa
Journal:  Mol Neurobiol       Date:  2019-05-10       Impact factor: 5.590

6.  Neurobehavioral Concerns Among Males with Dystrophinopathy Using Population-Based Surveillance Data from the Muscular Dystrophy Surveillance, Tracking, and Research Network.

Authors:  Kristin Caspers Conway; Katherine D Mathews; Pangaja Paramsothy; Joyce Oleszek; Christina Trout; Ying Zhang; Paul A Romitti
Journal:  J Dev Behav Pediatr       Date:  2015 Jul-Aug       Impact factor: 2.225

7.  In Vivo Evaluation of White Matter Abnormalities in Children with Duchenne Muscular Dystrophy Using DTI.

Authors:  V Preethish-Kumar; A Shah; M Kumar; M Ingalhalikar; K Polavarapu; M Afsar; J Rajeswaran; S Vengalil; S Nashi; P T Thomas; A Sadasivan; M Warrier; A Nalini; J Saini
Journal:  AJNR Am J Neuroradiol       Date:  2020-07-02       Impact factor: 3.825

Review 8.  Current Perspectives in Autism Spectrum Disorder: From Genes to Therapy.

Authors:  Maria Chahrour; Brian J O'Roak; Emanuela Santini; Rodney C Samaco; Robin J Kleiman; M Chiara Manzini
Journal:  J Neurosci       Date:  2016-11-09       Impact factor: 6.167

Review 9.  Diagnosis and management of Duchenne muscular dystrophy, part 3: primary care, emergency management, psychosocial care, and transitions of care across the lifespan.

Authors:  David J Birnkrant; Katharine Bushby; Carla M Bann; Susan D Apkon; Angela Blackwell; Mary K Colvin; Linda Cripe; Adrienne R Herron; Annie Kennedy; Kathi Kinnett; James Naprawa; Garey Noritz; James Poysky; Natalie Street; Christina J Trout; David R Weber; Leanne M Ward
Journal:  Lancet Neurol       Date:  2018-02-02       Impact factor: 44.182

10.  Descriptive Phenotype of Obsessive Compulsive Symptoms in Males With Duchenne Muscular Dystrophy.

Authors:  Angela J Lee; Edward T Buckingham; Aaron J Kauer; Katherine D Mathews
Journal:  J Child Neurol       Date:  2018-05-20       Impact factor: 1.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.